Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Laserscope to Seek Approval for Laser Cancer Treatment
May 1999
SAN JOSE, Calif., May 12 -- Laserscope will co-submit a Pre-Market Approval application to the US Food and Drug Administration for its Photodynamic Therapy (PDT) Laser Systems, in conjunction with Scotia Pharmaceuticals Ltd., UK's New Drug Application for Foscan. The submissions, expected to take place in September 1999, will be for the PDT treatment of head and neck cancer. Foscan has been assigned ``fast-track'' status by the FDA for the palliation of head and neck cancer. If granted, approval could come as early as six months after submission.

lasersNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.